Dynavax Technologies | 营业费用

Operating Expenses 更改 日
Adma Biologics USD 85.84M 27.26M 2023-12
Amgen USD 6.93B 2.11B 2023-12
AstraZeneca USD 9.54B 578M 2023-09
Dynavax Technologies USD 64.09M 311K 2023-12
Gilead Sciences USD 5.5B 1.08B 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09



Dynavax Technologies 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2024.